Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boada

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Early Detection of Mild Cognitive Impairment (MCI) in Primary CareM N Sabbagh, M Boada, S Borson, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2019
Trained dogs can identify malignant solitary pulmonary nodules in exhaled gasA Guirao, L Molins, I Ramón, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Early Detection of Mild Cognitive Impairment (MCI) in an At-Home SettingM N Sabbagh, M Boada, S Borson, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital TechnologiesM N Sabbagh, M Boada, S Borson, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriersR Ramirez-Lorca, M Boada, M E Saez, et al.
The Journal of Prevention of Alzheimer'S Disease|July 16, 2022
Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose FindingA Ruiz, D Sánchez, A Lafuente, et al.
Molecular Psychiatry|March 14, 2019
Correction: Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Molecular Psychiatry|May 3, 2017
Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.
The Journal of Prevention of Alzheimer'S Disease|December 7, 2017
Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task ForceP Aisen, J Touchon, S Andrieu, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Early Detection of Mild Cognitive Impairment (MCI) in Primary CareM N Sabbagh, M Boada, S Borson, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2019
Trained dogs can identify malignant solitary pulmonary nodules in exhaled gasA Guirao, L Molins, I Ramón, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Early Detection of Mild Cognitive Impairment (MCI) in an At-Home SettingM N Sabbagh, M Boada, S Borson, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital TechnologiesM N Sabbagh, M Boada, S Borson, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriersR Ramirez-Lorca, M Boada, M E Saez, et al.
The Journal of Prevention of Alzheimer'S Disease|July 16, 2022
Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose FindingA Ruiz, D Sánchez, A Lafuente, et al.
Molecular Psychiatry|March 14, 2019
Correction: Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Molecular Psychiatry|May 3, 2017
Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.
The Journal of Prevention of Alzheimer'S Disease|December 7, 2017
Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task ForceP Aisen, J Touchon, S Andrieu, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
Pageof 8